Spectral Med Inc (EDT)

Currency in CAD
1.300
-0.010(-0.76%)
Closed·
EDT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2701.310
52 wk Range
0.6201.840
Key Statistics
Bid/Ask
1.30 / 1.34
Prev. Close
1.31
Open
1.31
Day's Range
1.27-1.31
52 wk Range
0.62-1.84
Volume
11.2K
Average Volume (3m)
54.93K
1-Year Change
103.125%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EDT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.100
Upside
+138.46%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Spectral Med Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Spectral Med Company Profile

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Employees
29
Market
Canada

Compare EDT to Peers and Sector

Metrics to compare
EDT
Peers
Sector
Relationship
P/E Ratio
−9.1x−3.6x−0.5x
PEG Ratio
0.140.000.00
Price/Book
−5.5x1.2x2.6x
Price / LTM Sales
140.6x2.2x3.3x
Upside (Analyst Target)
138.5%127.3%47.1%
Fair Value Upside
Unlock17.8%5.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.100
(+138.46% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 07, 2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
675.00K / 541.00K
EPS Revisions
Last 90 days

People Also Watch

7.250
TCW
+4.62%
26.59
ARIS
+5.81%
25.31
POU
+0.32%
60.43
PPL
+1.82%
9.45
LAR
+4.65%

FAQ

What Is the Spectral Med (EDT) Share Price Today?

The live Spectral Med share price today is 1.300

What Stock Exchange Does Spectral Med (EDT) Trade On?

Spectral Med is listed and trades on the Toronto Stock Exchange.

What Is the Ticker (Stock Symbol) for Spectral Med?

The stock symbol (also called a 'ticker') for Spectral Med is "EDT."

What Is the Current Spectral Med Market Cap?

As of today, Spectral Med market capitalisation is 380.330M.

What Is Spectral Med's (EDT) Earnings Per Share (TTM)?

The Spectral Med EPS is currently -0.15 (Trailing Twelve Months).

When Is the Next Spectral Med Earnings Date?

Spectral Med's next earnings report will be released on 26/03/2026.

Is EDT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Spectral Med moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Spectral Med Stock Split?

Spectral Med has split 0 times. (See the EDT stock split history page for full effective split date and price information.)

How Many Employees Does Spectral Med Have?

Spectral Med has 29 employees.

What is the current trading status of Spectral Med (EDT)?

As of 15 Feb 2026, Spectral Med (EDT) is trading at a price of 1.300, with a previous close of 1.310. The stock has fluctuated within a day range of 1.270 to 1.310, while its 52-week range spans from 0.620 to 1.840.

What Is Spectral Med (EDT) Price Target According to Analysts?

The average 12-month price target for Spectral Med is CAD3.100, with a high estimate of CAD3.5 and a low estimate of CAD2.7. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +138.46% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.